Lutta, Anitta
Liu, Qian
Pedersen, Gabriel Kristian
Dong, Mingdong
Grohganz, Holger
Nielsen, Line Hagner
Schmidt, Signe Tandrup https://orcid.org/0000-0002-5631-571X
Funding for this research was provided by:
Danmarks Frie Forskningsfond (9041-00131b)
Danmarks Grundforskningsfond (DNRF122)
Villum Fonden (9301)
Article History
Accepted: 1 February 2025
First Online: 22 February 2025
Declarations
:
: Not relevant.
: All authors read and approved the final version of the manuscript and have had access to the raw data.
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: A.L., G.K.P., S.T.S. are employed at Statens Serum Institut, which is a non-profit government research facility and holds patents on the CAF®-based adjuvants. All other authors declare that there are no competing interests.